UK grant funding

Innovate UK (UKRI)

Advancing Innovation in Accelerated Cancer Diagnosis

Amount

Projects of £1.5m – £4m total eligible costs (grant 25% to 70% of costs, max £3m per enterprise)

Deadline

28/10/2026

Industry

HealthTech & BioTech

Location

National

About this grant

Innovate UK competition with up to £25.4 million for collaborative projects that develop, validate or evaluate diagnostic technologies or approaches for earlier cancer diagnosis, with clear potential for clinical and health economic impact. Projects on less common cancers (any cancer other than breast, prostate, lung and bowel, including rare forms of those four) are particularly encouraged. Companion diagnostics, therapeutics, discovery research, routine deployment of late-stage technologies, pure service redesign and recurrence or treatment-response monitoring are out of scope. Projects must have total eligible costs of £1.5 million to £4 million, last 24 to 36 months, start by 1 April 2027 and end by 31 March 2030. The competition opened on 1 September 2026 and closes at 11am on 28 October 2026.

Eligibility Criteria

How to apply — direct link

Unlock the full application details.

Create a free account to see the full eligibility criteria, the direct application link, and draft your application.

Create a Free Account to View

Already have an account? Sign in

Free to join · No card required · Takes 30 seconds